LumiraDx Stock Quote LMDX - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.016

Bid

0.014

Ask

0.0146

Volume

0.00 Day's Range 0.00

0.0151 52 Week Range 0.61

Market Cap

3.286M

Previous Close

0.016

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

164,322,000

Dividend Yield

PE Ratio

-0.01

Earnings Per Share (EPS)

-2.73

Revenue

254.48M

Net Profit

-447.79M

LumiraDx Ltd is a next-generation point of care diagnostics company. LumiraDx Ltd is a next-generation point of care diagnostics company.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.lumiradx.com

Headquarters

Grand Cayman, Cym

Founded

1970

LumiraDx Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LMDX. The last closing price for LumiraDx was $0.02. Over the last year, LumiraDx shares have traded in a share price range of $ 0.0151 to $ 0.61.

LumiraDx currently has 164,322,000 shares outstanding. The market capitalization of LumiraDx is $3.29 million. LumiraDx has a price to earnings ratio (PE ratio) of -0.01.

LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th

LONDON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX)(the “Company”) today announced that it has received notification from The Nasdaq Stock Market LLC (“Nasdaq”) that its...

LumiraDx Agrees to Sell Point-of-Care Tech Platform to Roche

By Stephen Nakrosis LumiraDx said Friday it will sell certain companies related to its point-of-care technology to Roche. Andrew Johnson, Lisa Rickelton and Lindsay Hallam of FTI Consulting, who...

LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche

LONDON, Dec. 29, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX) (the “Company”), a next generation point of care diagnostics company, announced today the appointment of joint...

LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal

LONDON, Oct. 27, 2023 (GLOBE NEWSWIRE) -- On October 24, 2023, LumiraDx Limited (Nasdaq: LMDX)(the “Company”) received a notice (“Notice”) from the Listing Qualifications Department (the...

LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub

Made possible thanks to unrestricted grant funding from AstraZeneca and run by the official charity of Everton Football Club – Everton in the Community – the Liverpool-based hub will provide...

LumiraDx Reports Second Quarter 2023 Results

LONDON, Aug. 24, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (NASDAQ: LMDX), a next-generation point of care (POC) diagnostics company, today announced financial results for its second quarter...

LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24

LONDON, Aug. 16, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, announced it will release its second quarter financial...

LumiraDx’s Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and Tests

Partnership between LumiraDx and Axonlab will allow Axonlab to sell the unique LumiraDx Point of Care testing solution and give LumiraDx the ability to expand the reach of the LumiraDx Platform...

LumiraDx Submits First 510(k) Application to the FDA for COVID Ultra Test

LONDON, June 30, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a leading innovator in diagnostic technologies, today announced the submission of its first 510(k) application to the...

LumiraDx Receives UK CTDA Approval for COVID Ultra and COVID & RSV Tests

LumiraDx SARS-CoV-2 Ag Ultra & SARS-CoV-2 Ag & RSV tests have been successfully validated by the Medicines and Healthcare products Regulatory Agency (MHRA) under the Coronavirus Test...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	-0.0891	-84.7764034253	0.1051	0.3059	0.0151	21236939	0.08751092	CS
52	-0.564	-97.2413793103	0.58	0.61	0.0151	8404691	0.13840862	CS
156	-9.874	-99.8382204247	9.89	11.0857	0.0151	2722587	0.34403559	CS
260	-9.874	-99.8382204247	9.89	11.0857	0.0151	2722587	0.34403559	CS

Symbol	Price	Vol.
AKLIAkili Inc	$ 0.3852 (63.98%)	79.5M
IMCCIM Cannabis Corporation	$ 0.85 (51.79%)	340.3k
GMMGlobal Mofy Metaverse Ltd	$ 1.38 (48.34%)	73.16M
WGSGeneDx Holdings Corporation	$ 16.30 (48.18%)	5.73M
CYCCCyclacel Pharmaceuticals Inc	$ 1.9897 (46.30%)	19.46M
CETXCemtrex Inc	$ 1.24 (-30.34%)	324.43k
LICNLichen China Limited	$ 1.42 (-30.05%)	1M
NRXPNRX Pharmaceuticals Inc	$ 2.6769 (-24.59%)	728.8k
LGHLWLion Group Holding Ltd	$ 0.0057 (-18.57%)	52
TWGTop Wealth Group Holding Ltd	$ 1.14 (-17.99%)	312.09k
TSLATesla Inc	$ 185.28 (-4.52%)	88.2M
AGBAAGBA Group Holding Ltd	$ 3.0868 (31.35%)	85.2M
EGOXNext e GO NV	$ 0.0305 (10.51%)	83.52M
SQQQProShares UltraPro Short QQQ	$ 11.73 (3.71%)	80.58M
JAGXJaguar Health Inc	$ 0.2319 (11.49%)	79.87M

Symbol

Price

Vol.

TSLATesla Inc

$ 185.28

(-4.52%)

88.2M

AGBAAGBA Group Holding Ltd

$ 3.0868

(31.35%)

85.2M

EGOXNext e GO NV

$ 0.0305

(10.51%)

83.52M

SQQQProShares UltraPro Short QQQ

$ 11.73

(3.71%)

80.58M

JAGXJaguar Health Inc

$ 0.2319

(11.49%)

79.87M

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

LumiraDx Ltd (LMDX) Quote

LumiraDx Ltd (LMDX)

Unlock more advanced trading tools

Key stats and details

About LumiraDx Ltd

LMDX Latest News

Market Movers

LMDX Discussion

Your Recent History

Company

Business

Popular

Get The App